These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30033768)

  • 21. Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes.
    Buyens K; Demeester J; De Smedt SS; Sanders NN
    Langmuir; 2009 May; 25(9):4886-91. PubMed ID: 19341292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid.
    Dakwar GR; Braeckmans K; Ceelen W; De Smedt SC; Remaut K
    Drug Deliv Transl Res; 2017 Apr; 7(2):241-251. PubMed ID: 27631392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy.
    Safari Sharafshadeh M; Tafvizi F; Khodarahmi P; Ehtesham S
    Int J Biol Macromol; 2023 Apr; 235():123686. PubMed ID: 36801304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
    Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
    J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
    Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
    Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
    Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
    Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.
    Xiao Y; Jaskula-Sztul R; Javadi A; Xu W; Eide J; Dammalapati A; Kunnimalaiyaan M; Chen H; Gong S
    Nanoscale; 2012 Nov; 4(22):7185-93. PubMed ID: 23070403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines.
    Chen L; Alrbyawi H; Poudel I; Arnold RD; Babu RJ
    AAPS PharmSciTech; 2019 Feb; 20(3):99. PubMed ID: 30719596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.
    Gu L; Nusblat LM; Tishbi N; Noble SC; Pinson CM; Mintzer E; Roth CM; Uhrich KE
    J Control Release; 2014 Jun; 184():28-35. PubMed ID: 24727076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis.
    Kornek M; Lukacs-Kornek V; Limmer A; Raskopf E; Becker U; Klöckner M; Sauerbruch T; Schmitz V
    Mol Med; 2008; 14(7-8):365-73. PubMed ID: 18392108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cationic Liposome- Multi-Walled Carbon Nanotubes Hybrids for Dual siPLK1 and Doxorubicin Delivery In Vitro.
    Pereira S; Lee J; Rubio N; Hassan HA; Suffian IB; Wang JT; Klippstein R; Ballesteros B; Al-Jamal WT; Al-Jamal KT
    Pharm Res; 2015 Oct; 32(10):3293-308. PubMed ID: 26085038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery.
    Podesta JE; Kostarelos K
    Methods Enzymol; 2009; 464():343-54. PubMed ID: 19903563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes.
    Geusens B; Lambert J; De Smedt SC; Buyens K; Sanders NN; Van Gele M
    J Control Release; 2009 Feb; 133(3):214-20. PubMed ID: 18973779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biological activity of cationic liposomes in drug delivery and toxicity test in animal models.
    Qi P; Cao M; Song L; Chen C; Liu M; Li N; Wu D; Peng J; Hu G; Zhao J
    Environ Toxicol Pharmacol; 2016 Oct; 47():159-164. PubMed ID: 27694054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.
    Boakye CH; Patel K; Singh M
    Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.